Fact Check Team: How young Is too young for GLP-1 medications?
byMORGAN STEPHENS| Fact Check Team
Fri, July 10th 2026 at 12:00 PM
3
VIEW ALL PHOTOS
LOS ANGELES, CALIFORNIA – APRIL 17: In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. Ozempic was originally approved by the FDA to treat people with Type 2 diabetes- who risk serious health consequences without medication. In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight loss benefits, which has led to shortages. Some doctors prescribe Ozempic off-label to treat obesity. (Photo illustration by Mario Tama/Getty Images)
-
GLP-1WegovyZepboundAdolescentsMedicareObesityFDA approvalWeight-loss
WASHINGTON (TNND) —GLP-1 medications have transformed the way doctors treat obesity in adults — but as demand grows, a new question is emerging: how young is too young to use these drugs?
Medications like Wegovy and other GLP-1 drugsare now being prescribed to some teenagersstruggling with obesity, raising questions among parents, doctors, and researchers about the benefits, risks, and long-term impact on children
When can kids take GLP-1 medications?
The answer depends on the specific medication
The FDA has approved certain GLP-1 medications for adolescents, but they are not approved for all children. For example, Wegovy is approved for chronic weight management in adolescents ages 12 and older who meet certain medical criteria, including obesity
Doctors typically consider these medications only after other approaches — such as nutrition changes, increased physical activity, and behavioral support — have not been enough
The medications are not intended as a quick fix or for children looking to lose a few pounds. They are generally consideredfor young people with obesity, which is associated with increased risks of health problems like type 2 diabetes, high blood pressure, and heart disease
Why are doctors using GLP-1 drugs in children?
Supporters say treating obesity early can help prevent serious health problems later in life
Clinical trials in adolescents have found GLP-1 medications can lead to significant weight loss when combined with lifestyle changes. Some doctors argue that obesity is a chronic disease that should be treated with every effective tool available
They also point out that many children with severe obesity face health risks at a young age — and waiting until adulthood may allow those problems to worsen
Critics say there are still unanswered questions about the long-term effects of using GLP-1 medications during childhood and adolescence
Concerns include:
- How long children will need to stay on the medications
- What happens when they stop taking them
- Potential side effects over many years of use
- Whether medication could replace healthy lifestyle changes
Common side effects of GLP-1 drugs can include nausea, vomiting, diarrhea, and stomach-related issues. More serious risks are rare but can include complications such as inflammation of the pancreas or gallbladder problems
GLP-1 medications are now accepted through Medicare
Meanwhile, starting July 1, Medicare launched atemporary program known as the GLP-1 Bridge Program, allowing certain Medicare Part D beneficiaries to access eligible weight-loss GLP-1 medications for a $50 monthly copay
The program currently includes Wegovy and certain forms of Zepbound, two medications approved for chronic weight management. The goal is to provide a temporary pathway for eligible patients while broader questions about Medicare coverage of weight-loss medications continue
Who qualifies?
The program is not available to every Medicare beneficiary. Patients must meet eligibility requirements, including enrollment in a qualifying Medicare Part D plan and other program criteria. Coverage may also depend on whether a patient meets medical requirements for the medication
Health experts say access remains one of the biggest challenges surrounding GLP-1 drugs. While the medications have shown significant benefits for many patients, their list prices can reach hundreds or even thousands of dollars per month without insurance coverage
Stay Connected
© 2026 Sinclair, Inc.
TermsPrivacy PolicyCookie PolicyCookie Preferences
